JUNE 30, 2004
VOLUME 1 NO. 13
 

Colons are crying for spilt milk

LEBANON, NH — Calcium supplements could be key to cutting down on polyp risk, according to a study in the June issue of the Journal of the National Cancer Institute. Researchers looked at 930 patients with an average age of 61, divided into two groups -- one took a 1,200mg calcium supplement, the other placebo. After four years, those who took the supplement had 18% fewer noncancerous polyps and 35% fewer advanced polyps than the placebo group.

The apple of my age-related maculopathy

BOSTON — An apple or three a day might indeed keep the doctor away -- well, at least the ophthalmologist. New research shows that three or more servings a day of fruit can protect against age-related maculopathy (ARM). The large study, in June's Archives of Ophthalmology, looked at close to 120,000 patients. Those who consumed three or more servings of fruit each day had a 36% lower risk of developing neovascular ARM. Sadly, vegetables had no effect.

Supersize me -- and him, and her

BOSTON — The study design was simple (if somewhat reminiscent of a current box office smash): feed a group of teens supersize fast food meals and watch what happens. The results, in the June issue of JAMA, show that while most teens tend to overeat when they hit the food court the leaner ones are more likely to eat less after a junk meal than their obese peers. The authors conclude that "fast food consumption serves to maintain or exacerbate obesity."

Hard facts on soft drinks

ORLANDO — Looks like the Pepsi generation might be in for some bad news. New research links carbonated beverages to an increased risk of type II diabetes in women. But the link isn't exactly mysterious: the study, presented at the American Diabetes Association 64th Scientific Sessions, shows that women who knocked back more than one pop per day gained more weight (5kg over four years) and therefore doubled their diabetes risk.

Looking for FPs in all the wrong places

OTTAWA — A new Statistics Canada survey finds a whopping 3.6 million Canadians don't have a doctor to call their own. Although only a measly 1.2 million of the doctor-less actually tried to find themselves a family physician, many who looked long and hard came up empty-handed. Health policy experts often trace the roots of Canada's doctor shortage to 1991's Barer-Stoddart report which recommended cutting Canada's med school entry slots by 10%.

Flower shmower

MARSHFIELD, WS/HACKENSACK, NJ — The efficacy of a common herbal cold remedy, Echinacea purpurea supplements, found globally in VW van glove compartments, has been called into question by two recent studies. One, in the June 14th issue of the Archives of Internal Medicine, found no evidence that the herb prevents the common cold or reduces its symptoms. Another, in the May 15 issue of Clinical Infectious Diseases, focused on the herb's alleged cold-prevention powers. Echinacea again failed spectacularly -- over 90% of test subjects on the herb caught a cold as soon as they were exposed to the virus.

Connect the clots

VIENNA — New research shows that once men have had a venous thromboembolism, they're likely to experience a clot revisitation. Researchers originally thought that women would be at higher risk, but after looking at 826 patients data revealed that men had a threefold higher incidence of recurrence. The reasons remain a mystery. The results appear in the June 17 issue of the New England Journal of Medicine.

That cat must be on the reefer, man

NEW HAVEN, CT — A new study, in the online edition of Neuropsychopharmacology, looks at schizophrenia-like symptoms induced by the juice, ã-9-THC, that gives marijuana its kick. High-as-kite test subjects displayed a host of psychotic symptoms like paranoia, euphoria and high cortisol levels; many also suffered from acute munchies. All symptoms disappeared within 30 to 60 minutes of taking the drug and participants showed no side effects in followup visits one to six months later. The Yale-based researchers hope studying THC's effects will help shed light on the causes of psychosis.

Statins help elderly see the light

BIRMINGHAM, AL — There may be some light at the end of the tunnel for people at risk for glaucoma. A new study reveals that longterm use of statins may reduce the risk for developing this disease, especially in patients with hypertension and cardiovascular disease. The study looked at data from the medical records of 667 men aged 50 or older. The results were published in the June issue of the Archives of Ophthalmology.

Found some CAD with the MRS

LOS ANGELES — Magnetic resonance spectroscopy (MRS) can reliably predict the likelihood of cardiovascular events in women with chest pains, even if they don't appear to have coronary artery disease (CAD), says a report published online June 15 in the rapid access section of Circulation. Of the 74 women tested, 14 who had abnormal MRS results were significantly more likely to suffer from angina in the next three years. The authors of the study conclude that MRS will soon be an important diagnostic tool for coronary disease.

Cox-2 kicks prostate cancer where it hurts

CHAPEL HILL, NC — Cox-2 inhibitor celecoxib appears to have anti-tumour qualities, according to early findings from a University of North Carolina study led by urologist Dr J Eric Derksen presented at the Annual Meeting of the American Society of Clinical Oncology. The two-year study looked at men with rising prostate-specific antigen (PSA). Ninety-two percent of those on the Cox-2 inhibitor showed improved PSA levels.

Judge for yourself

NEW YORK — GlaxoSmithKline has spoken out about a lawsuit which alleges they suppressed negative data about paroxetine use in pediatric patients. The pharma company denies the claims, saying they did publicize results from trials showing that the antidepressant is generally ineffective in children and adolescents and could actually increase suicidal behaviour. They've now made the data from nine different clinical trials available on their website.
1
2

 

 

back to top of page

 

 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.